Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation

• Publication date

  2002-06-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000016826.62813.F5PMID 12045175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consequences of Atrial Tachycardia-Induced Remodeling Depend on the Preexisting Atrial Substrate

  2002cited by this paper
• Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation.

  2001cited by this paper
• Recovery of electrophysiological parameters after conversion of atrial fibrillation.

  2001cited by this paper
• Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure

  2001cited by this paper
• Structural remodelling during chronic atrial fibrillation: act of programmed cell survival.

  2001cited by this paper
• Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation

  2000cited by this paper
• Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

  2000cited by this paper
• Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans.

  2000cited by this paper
• Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation.

  2000cited by this paper
• Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence.

  2000cited by this paper
• Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man.

  1999cited by this paper
• Regional differences in the recovery course of tachycardia-induced changes of atrial electrophysiological properties.

  1999cited by this paper
• Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

  1999cited by this paper
• Susceptibility to Atrial Fibrillation:

  1998cited by this paper
• Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.

  1998cited by this paper
• Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study.

  1997cited by this paper
• Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart.

  1997cited by this paper
• Effects of Intravenous Anesthetics on Atrial Wavelength and Atrioventricular Nodal Conduction in Guinea Pig Heart: Potential Antidysrhythmic Properties and Clinical Implications

  1996cited by this paper
• Unequal Atrial Stretch in dogs Increases Dispersion of Refractoriness Conducive to developing Atrial Fibrillation

  1996cited by this paper
• Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

  1995cited by this paper
• Cyclic GMP‐mediated inhibition of L‐type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells

  1995cited by this paper
• High prevalence of atrial fibrosis in patients with dilated cardiomyopathy.

  1995cited by this paper
• Effects of An Acute Increase in Atrial Pressure on Atrial Refractoriness in Humans

  1992cited by this paper
• Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium.

  1990cited by this paper
• Atrial fibrillation in halothane- and isoflurane-anesthetized dogs.

  1990cited by this paper
• The effect of atrial dilatation on the genesis of atrial arrhythmias.

  1989cited by this paper
• Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure.

  1989cited by this paper
• Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old.

  1988cited by this paper
• Right atrial ultrastructure in chronic rheumatic heart disease

  1982cited by this paper
• Right atrial ultrastructural in chronic rheumatic heart disease.

  1982cited by this paper
• Epidemiologic features of chronic atrial fibrillation: the Framingham study.

  1982cited by this paper
• Influence of Secobarbital and a‐Chloralose, and of Vagal and Sympathetic Interruption, on Left Ventricular Activation after Acute Coronary Artery Occlusion in the Dog

  1981cited by this paper
• Maintenance of sinus rhythm after atrial defibrillation.

  1970cited by this paper

• Atrial fibrillation ablation timing: where is the sweet spot?

  2025cites this paper
• Analysis of Similarities and Differences between Biatrial Remodeling Through Electro-Anatomic Mapping in Patients with Atrial Fibrillation

  2025cites this paper
• Identification of key genes associated with atrial fibrillation and hypoxia using WGCNA and machine learning technology

  2025cites this paper
• Understanding the Diseased Atria.

  2025cites this paper
• Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Insights and Unresolved Questions.

  2025cites this paper
• Angiogenesis in Atrial Fibrillation: A Literature Review

  2025cites this paper
• Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches

  2024cites this paper
• Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme.

  2024cites this paper
• 2023 Cardiac Society of Australia and New Zealand Expert Position Statement on Catheter and Surgical Ablation for Atrial Fibrillation.

  2024cites this paper
• Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets

  2024cites this paper
• Breathless Nights and Heart Flutters: Understanding the Relationship Between Obstructive Sleep Apnea and Atrial Fibrillation.

  2023cites this paper
• A prediction model for new-onset atrial fibrillation following coronary artery bypass graft surgery: A multicenter retrospective study.

  2023cites this paper
• Increased Risk for Atrial Alternans in Rabbit Heart Failure: The Role of Ca2+/Calmodulin-Dependent Kinase II and Inositol-1,4,5-trisphosphate Signaling

  2023cites this paper
• New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models

  2023cites this paper
• The value of serial echocardiography in risk assessment of patients with paroxysmal atrial fibrillation

  2023cites this paper
• Should cryoballoon ablation of paroxysmal atrial fibrillation be proposed as a first-line treatment?

  2022cites this paper
• Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1

  2022cites this paper
• Animal Models to Study Cardiac Arrhythmias

  2022cites this paper
• Electrophysiological Consequences of Cardiac Fibrosis

  2021cites this paper
• Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation

  2021cites this paper
• Paroxysmal atrial fibrillation in a dog that was presented for neck wounds.

  2021cites this paper
• Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study

  2021cites this paper
• Risk Factors for Atrial Fibrillation Progression.

  2021cites this paper
• Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management

  2021cites this paper
• Atrial Fibrillation and Obesity: Reverse Remodeling of Atrial Substrate With Weight Reduction.

  2021cites this paper
• Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension

  2021cites this paper
• Pathophysiology of atrial fibrillation. Systemic review Patofizjologia migotania

  2021cites this paper
• WNT signaling in atrial fibrillation

  2021cites this paper
• Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation

  2021cites this paper
• Atrial Fibrillation Structural Substrates: Aetiology, Identification and Implications

  2020cites this paper
• Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.

  2020cites this paper
• Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway

  2020cites this paper
• Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines

  2020cites this paper
• [Review Articles].

  2020cites this paper
• Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem.

  2019cites this paper
• Association between atrial fibrillation and right-sided manifestations of congestive heart failure in dogs with degenerative mitral valve disease or dilated cardiomyopathy.

  2019cites this paper
• Role of miRNA-21 expression in profibrillatory fibrotic remodeling and atrial fibrillation occurrence

  2019cites this paper
• Metabolic modulators as a treatment of atrial fibrillation

  2019cites this paper
• Risk factors and outcomes of new-onset atrial fibrillation in patients hospitalized in an internal medicine ward: a case–control study

  2019cites this paper
• Remodeling in Atrial Fibrillation

  2019cites this paper
• Animal models of arrhythmia: classic electrophysiology to genetically modified large animals

  2019cites this paper
• Atrial Dyssynchrony: A New Predictor for Atrial High-Rate Episodes in Patients with Cardiac Resynchronization Therapy

  2019cites this paper
• Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

  2018cites this paper
• Mechanisms and Clinical Significance of Arrhythmia-Induced Cardiomyopathy.

  2018cites this paper
• Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure

  2018cites this paper
• Calcium‐dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow‐derived mesenchymal stem cells

  2018cites this paper
• Atrial Fibrillation Mechanisms and Implications for Catheter Ablation

  2018cites this paper
• N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review

  2018cites this paper
• University of Groningen Atrial remodeling due to atrial tachycardia and heart failure Schoonderwoerd,

  2018cites this paper
• Induction of atrial endothelial senescence by angiotensin II and thrombin : role of oxidative stress and characterization of pro-thrombotic, pro-adhesive, proteolytic and pro-fibrotic phenotype

  2018cites this paper
• Absence of natriuretic peptide clearance receptor attenuates TGF-&bgr;1-induced selective atrial fibrosis and atrial fibrillation

  2018cites this paper
• Stanley Nattel.

  2018cites this paper
• The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future

  2018cites this paper
• Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation

  2018cites this paper
• Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats.

  2018cites this paper
• Proteomics and transcriptomics in atrial fibrillation

  2018cites this paper
• Surgical ablation for the treatment of atrial fibrillation in different patient populations : A study of clinical outcomes including rhythm, quality of life, atrial function and safety

  2018cites this paper
• Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?

  2017cites this paper
• Association of P wave duration index with atrial fibrillation recurrence after cryoballoon catheter ablation.

  2017cites this paper
• Biophysical aspects and novel treatments of atrial fibrillation.

  2017cites this paper
• Leads to improve atrial fibrillation ablation, catheters, imaging and mapping guidance

  2017cites this paper
• Évaluation initiale d’une méthode de dépistage de la fibrillation atriale paroxystique

  2017cites this paper
• Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS

  2017cites this paper
• 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

  2017cites this paper
• Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?

  2017cites this paper
• Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?

  2017cites this paper
• Influence de l'âge et du rythme en début de procédure d'ablation de fibrillation atriale persistante sur les récidives et le remodelage cardiaque

  2016cites this paper
• Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.

  2016cites this paper
• Risk Factors and Genetics of Atrial Fibrillation.

  2016cites this paper
• Persistent Atrial Fibrillation From the Onset: A Specific Subgroup of Patients With Biatrial Substrate Involvement and Poorer Clinical Outcome.

  2016cites this paper
• Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.

  2016cites this paper
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  2016cites this paper
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  2016cites this paper
• Relaxin Level in Patients With Atrial Fibrillation and Association with Heart Failure Occurrence

  2016cites this paper
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  2016cites this paper
• Vidarabine, an Anti-Herpes Virus Agent, Protects Against the Development of Heart Failure With Relatively Mild Side-Effects on Cardiac Function in a Canine Model of Pacing-Induced Dilated Cardiomyopathy.

  2016cites this paper
• [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].

  2016cites this paper
• Cilostazol Prevents Atrial Structural Remodeling through the MEK/ERK Pathway in a Canine Model of Atrial Tachycardia

  2016cites this paper
• Effects of cardiac structural remodelling during heart failure on cardiac excitation - insights from a heterogeneous 3D model of the rabbit atria

  2015cites this paper
• Age-Related Electrophysiological Changes of the Atrial Myocardium in Patients with Paroxysmal Atrial Fibrillation

  2015cites this paper
• Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.

  2015cites this paper
• Modeling Atrial Fibrillation using Human Embryonic Stem Cells

  2015cites this paper
• MMP-9 in atrial remodeling in patients with atrial fibrillation.

  2015cites this paper
• When it comes to atrial fibrillation recurrence, perhaps we should look both left and right.

  2015cites this paper
• MMP-9 dans le remodelage des oreillettes chez les malades atteints de fibrillation atriale

  2015cites this paper
• Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.

  2014cites this paper
• Inside Molecular Mechanisms and Pharmacological Targets of Atrial Fibrillation

  2014cites this paper
• Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model.

  2014cites this paper
• Risk factors and genetics of atrial fibrillation.

  2014cites this paper
• Atrial fibrillation and obesity: characterization of electro-structural atrial substrate with sustained obesity and reversal upon weight reduction.

  2014cites this paper
• The Propensity for Inducing Atrial Fibrillation: A Comparative Study on Old versus Young Rabbits

  2014cites this paper
• Atrial remodeling: new pathophysiological mechanism of atrial fibrillation.

  2013cites this paper
• The Role of Matrix Metalloproteinase-2 in the Treatment of Atrial Fibrillation Recurrence after a Radiofrequency Modified Maze Procedure

  2013cites this paper
• Transient receptor potential (TRP) channels and cardiac fibrosis.

  2013influential citation
• Atrial Fibrillation and Heart Failure: Rate Versus Rhythm Control

  2013cites this paper
• Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation. Part I: atrial structures (atrial myocardium and coronary sinus).

  2013cites this paper
• Upstream therapy for atrial fibrillation in heart failure.

  2013cites this paper
• n‐3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI‐HF trial

  2013cites this paper
• Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

  2013cites this paper
• Ventricular rate control of atrial fibrillation in heart failure.

  2013cites this paper